# Lachnospiraceae‐Derived Extracellular Vesicles Mediate the Cardioprotective Effects of Barley Leaf in Myocardial Infarction by Improving Intestinal Stem Cell Function

**Authors:** Wenjing Chen, Yifan Zhao, Qian Zhao, Yingzhuo Zhou, Chen Ma, Li Dong, Yinghua Luo, Zhong Zhang, Fang Chen, Xiaosong Hu, Daotong Li

PMC · DOI: 10.1002/jev2.70250 · 2026-03-10

## TL;DR

Barley leaf protects the heart after a heart attack by improving gut health through Lachnospiraceae bacteria-derived extracellular vesicles.

## Contribution

The study identifies Lachnospiraceae-derived extracellular vesicles as mediators of barley leaf's cardioprotective effects via modulation of gut stem cell function.

## Key findings

- Barley leaf supplementation improves cardiac function and reduces adverse remodelling after myocardial infarction.
- Lachnospiraceae-derived extracellular vesicles enhance gut barrier function and protect the heart through estrogen-like metabolites.
- Supplementing with live Lachnospiraceae, but not heat-inactivated, reduces myocardial injury in mice.

## Abstract

Ischaemic cardiovascular diseases, particularly myocardial infarction (MI), remain the leading causes of morbidity and mortality worldwide. Targeting extracellular vesicles (EVs) from the gut microbiota by diet may provide opportunities to improve cardiovascular health. Barley leaf (BL) has a long history of use in Traditional Chinese medicine and has been found to beneficially influence the gut microbial composition. Herein, we used a murine model of MI to explore the mechanistic role of gut bacteria‐derived EVs in the cardioprotective effects of BL. Dietary supplementation of BL remarkably improved cardiac function and ameliorated adverse remodelling in experimental MI. The cardioprotective effects of BL were linked to enhanced gut epithelial barrier and suppressed transfer of bacterial‐derived lipopolysaccharide. Moreover, BL alleviated MI‐induced gut microbial dysbiosis, with an enrichment of Lachnospiraceae. Gut microbiota depletion by antibiotic treatment abolished the cardioprotective effects of BL. Furthermore, mice receiving microbiota from BL‐fed mice had better cardiac outcomes after MI compared to mice receiving microbiota from mice without BL supplementation. Notably, we identified that BL increased the abundance of Lachnospiraceae_NK4A136_group, a commensal member of the family Lachnospiraceae. Supplementing antibiotic‐treated mice with live but not heat‐inactivated Lachnospiraceae ameliorated myocardial injury and cardiac remodelling in MI mice. We isolated EVs from Lachnospiraceae and demonstrated that Lachnospiraceae‐derived EVs (L‐EVs) achieved desirable biosafety, stability and colonic retention effects following oral administration. Mechanistically, estrogen‐like metabolites from L‐EVs modulated the estrogen receptor alpha (ERα)‐solute carrier family 6 member 14 (Slc6a14)‐Hippo signalling pathway to promote intestinal stem cell function and ultimately protected against MI‐induced adverse remodelling. Our study thus provides novel insights into the role of the microbiota–gut–heart axis in the pathophysiology of MI and underscores the great potential of gut bacteria‐derived EVs to reduce pathological outcomes after MI through improving gut health.

## Linked entities

- **Genes:** ESR1 (estrogen receptor 1) [NCBI Gene 2099], SLC6A14 (solute carrier family 6 member 14) [NCBI Gene 11254]
- **Diseases:** myocardial infarction (MONDO:0005068)
- **Species:** Lachnospiraceae (taxon 186803)

## Full-text entities

- **Genes:** Esr1 (estrogen receptor 1 (alpha)) [NCBI Gene 13982] {aka ER, ER-alpha, ERa, ERalpha, ESR, Estr}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, SLC6A14 (solute carrier family 6 member 14) [NCBI Gene 11254] {aka BMIQ11}, MAP3K10 (mitogen-activated protein kinase kinase kinase 10) [NCBI Gene 4294] {aka MEKK10, MLK2, MST}, DNM2 (dynamin 2) [NCBI Gene 1785] {aka CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, WWTR1 (WW domain containing transcription regulator 1) [NCBI Gene 25937] {aka TAZ}, LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549] {aka FEX, GPR49, GPR67, GRP49, HG38}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Slc6a14 (solute carrier family 6 (neurotransmitter transporter), member 14) [NCBI Gene 56774] {aka 1110007A17Rik, 9030613J17Rik, ATB0plus, CATB0plus}, SGK1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 6446] {aka SGK}, Glb1 (galactosidase, beta 1) [NCBI Gene 12091] {aka Bge, Bgl, Bgl-e, Bgl-s, Bgl-t, Bgs}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, CCN1 (cellular communication network factor 1) [NCBI Gene 3491] {aka CYR61, GIG1, IBP-10, IGFBP-10, IGFBP10}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Cldn3 (claudin 3) [NCBI Gene 12739] {aka Cpetr2, mRVP1}, Dntt (deoxynucleotidyltransferase, terminal) [NCBI Gene 21673] {aka Tdt}, Ctsg (cathepsin G) [NCBI Gene 13035] {aka CatG, VSP}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, Hspd1-ps3 (heat shock protein 1 (chaperonin), pseudogene 3) [NCBI Gene 432551] {aka Gm12141, Hspd1-1p}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901] {aka BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX}, CCN2 (cellular communication network factor 2) [NCBI Gene 1490] {aka CTGF, HCS24, IBP-8, IGFBP8, KMD, NOV2}, Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}
- **Diseases:** atherosclerosis (MESH:D050197), death (MESH:D003643), endotoxemia (MESH:D019446), post (MESH:D000094025), myocardial hypertrophy (MESH:D006984), colitis (MESH:D003092), MI (MESH:D009203), CVDs (MESH:D002318), infection (MESH:D007239), coronary artery disease (MESH:D003324), Cardiac Dysfunction (MESH:D006331), adverse remodelling (MESH:D020257), heart failure (MESH:D006333), infarct (MESH:D007238), depression (MESH:D003866), mucosal injury (MESH:D052016), artery thrombosis (MESH:D002341), myocardial remodelling (MESH:D064752), cardiac fibrosis (MESH:D005355), cardiometabolic dysfunction (MESH:D024821), cardiomyocyte injury (MESH:D014947), cardiac inflammation (MESH:D007249), LV dilation (MESH:C565277), Barrier Dysfunction (MESH:C536830), Microbiota Dysbiosis (MESH:D064806), cancer (MESH:D009369), Myocardial Injury (MESH:D009202), gestational diabetes mellitus (MESH:D016640), LV dysfunction (MESH:D018487), Haemolysis (MESH:D006461)
- **Chemicals:** glycerin (MESH:D005990), penicillin (MESH:D010406), Haematoxylin (MESH:D006416), alpha-methyltryptophan (MESH:C020774), H&amp;E (MESH:D006371), NaHCO3 (MESH:D017693), BL (-), fatty acid (MESH:D005227), PKH26 (MESH:C070080), estriol (MESH:D004964), propanoate (MESH:D011422), cornstarch (MESH:D013213), UREA (MESH:D014508), dUTP (MESH:C027078), agarose (MESH:D012685), LPS (MESH:D008070), paraformaldehyde (MESH:C003043), lipid (MESH:D008055), L-cysteine (MESH:D003545), CO2 (MESH:D002245), glutathione (MESH:D005978), Evans blue (MESH:D005070), short-chain fatty acids (MESH:D005232), neomycin (MESH:D009355), CREA (MESH:D003404), DAPI (MESH:C007293), H (MESH:D006859), DAB (MESH:C000469), eosin (MESH:D004801), sphingolipid (MESH:D013107), oxygen (MESH:D010100), acids (MESH:D000143), 2,3,5-triphenyltetrazolium chloride (MESH:C009591), formic acid (MESH:C030544), DS (MESH:C511794), Optiprep (MESH:C044834), methanol (MESH:D000432), methionine (MESH:D008715), paraffin (MESH:D010232), metronidazole (MESH:D008795), streptomycin (MESH:D013307), carbon (MESH:D002244), EDTA (MESH:D004492), N2 (MESH:D009584), polysaccharides (MESH:D011134), TRIzol (MESH:C411644), vancomycin (MESH:D014640), isoflurane (MESH:D007530), luminal (MESH:D010634), estetrol (MESH:D004953), L (MESH:D007930), water (MESH:D014867), AB (MESH:D000423), galactose (MESH:D005690), glyoxylate (MESH:C031150), HCl (MESH:D006851), fulvestrant (MESH:D000077267), biotin (MESH:D001710)
- **Species:** Roseburia intestinalis (species) [taxon 166486], Clostridioides difficile (species) [taxon 1496], Homo sapiens (human, species) [taxon 9606], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Lactobacillus johnsonii (species) [taxon 33959], Rattus norvegicus (brown rat, species) [taxon 10116], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Bacteroidia (class) [taxon 200643], Hordeum vulgare (barley, species) [taxon 4513], Bifidobacterium longum (species) [taxon 216816], Mus musculus (house mouse, species) [taxon 10090], Eubacterium (genus) [taxon 1730], Desulfovibrio (genus) [taxon 872], Lactobacillus helveticus (species) [taxon 1587]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12974910/full.md

---
Source: https://tomesphere.com/paper/PMC12974910